Facebook
Twitter
Telegram
Report an ErrorUroGen Pharma Ltd. Financial Statements 2011-2024 | URGN
Annual Financial Statements UroGen Pharma Ltd.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
413 M | 193 M | 173 M | 487 M | 617 M | 654 M | 484 M | - | - | - | - | - | - |
Shares |
28.8 M | 22.8 M | 22.3 M | 22.1 M | 20.5 M | 15.8 M | 9.72 M | - | - | - | - | - | - |
Historical Prices |
14.3 | 8.48 | 7.72 | 22.1 | 29.4 | 41.4 | 49.1 | - | - | - | - | - | - |
Net Income |
-102 M | -110 M | -111 M | -128 M | -105 M | -75.7 M | -20 M | -1.94 M | -12.7 M | - | - | - | - |
Revenue |
82.7 M | 64.4 M | 48 M | 11.8 M | 18 K | 1.13 M | 8.16 M | 17.5 M | - | - | - | - | - |
Cost of Revenue |
9.36 M | 7.65 M | 5.16 M | 1.01 M | - | 1.8 M | 600 K | 28 K | - | - | - | - | - |
Gross Profit |
73.4 M | 56.7 M | 42.9 M | 10.8 M | 18 K | -675 K | 7.56 M | 17.5 M | - | - | - | - | - |
Operating Income |
-65.5 M | -79 M | -92.3 M | -127 M | -109 M | -77.2 M | -20 M | 798 K | -12.4 M | - | - | - | - |
Interest Expense |
- | - | - | - | -284 K | -124 K | 12 K | - | - | - | - | - | - |
EBITDA |
-64.7 M | -78.1 M | -91.5 M | -125 M | -108 M | -76.8 M | -19.7 M | 1.01 M | -12.3 M | - | - | - | - |
Operating Expenses |
- | - | - | 138 M | 109 M | 76.5 M | 27.5 M | 16.7 M | - | - | - | - | - |
General and Administrative Expenses |
93.3 M | 82.8 M | 87.5 M | 90.2 M | 60.2 M | 39.6 M | 8.81 M | 6.42 M | 1.9 M | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement UroGen Pharma Ltd.
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
32.3 M | 23.5 M | 23.3 M | 23.1 M | 22.8 M | 22.7 M | 22.6 M | 22.5 M | 22.4 M | 22.3 M | 22.2 M | 22.2 M | 22.1 M | 21.8 M | 21.2 M | 21 M | 20.9 M | 20.8 M | 19.3 M | 16.2 M | 16.1 M | 15.8 M | 15.3 M | 13.8 M | 13.1 M | 9.2 M | 2.31 M | 2.31 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-21.9 M | -24.1 M | -30.2 M | - | -25.8 M | -26.7 M | -28.4 M | - | -30.2 M | -26.2 M | -25.9 M | - | -28.8 M | -31.3 M | -37.8 M | -39 M | -22.3 M | -22.5 M | -21.4 M | -23.7 M | -20.5 M | -18 M | -13.4 M | -10.1 M | -298 K | -6.2 M | -3.42 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
20.9 M | 21.1 M | 17.2 M | - | 16.1 M | 16.6 M | 13.6 M | - | 11.4 M | 13 M | 7.48 M | - | 3.46 M | 372 K | - | - | 18 K | 18 K | - | - | 283 K | 364 K | 481 K | 327 K | 7.81 M | - | 19 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
2.37 M | 2.44 M | 2.26 M | - | 2.02 M | 1.85 M | 1.52 M | - | 1.24 M | 1.43 M | 897 K | - | 309 K | 48 K | - | - | - | - | - | - | 1.06 M | 318 K | 430 K | - | 295 K | - | 18 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
18.5 M | 18.7 M | 14.9 M | - | 14.1 M | 14.8 M | 12 M | - | 10.1 M | 11.6 M | 6.59 M | - | 3.15 M | 324 K | - | - | 18 K | 18 K | - | - | -772 K | 46 K | 51 K | - | 7.52 M | - | 1 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-13.5 M | -15.4 M | -22 M | - | -18.1 M | -18.7 M | -22 M | - | -23.4 M | -22.8 M | -26.1 M | - | -29.1 M | -31.8 M | -38.6 M | -39.8 M | -23.5 M | -23.8 M | -22.4 M | -24 M | -21.1 M | -18.4 M | -13.6 M | -10.2 M | -303 K | -5.95 M | -3.54 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.39 M | 911 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-13.3 M | -15.2 M | -21.8 M | - | -17.9 M | -18.5 M | -21.7 M | - | -23.2 M | -22.6 M | -25.9 M | - | -29 M | -31.7 M | -38.5 M | -39.8 M | -23.4 M | -23.7 M | -22.3 M | -24 M | -21 M | -18.4 M | -13.4 M | -10.2 M | -303 K | -5.95 M | -3.54 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 39.8 M | 23.5 M | 23.8 M | 22.4 M | 24 M | 20.3 M | 18.5 M | 13.7 M | 10.2 M | 7.82 M | 5.95 M | 3.54 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
21.8 M | 22.5 M | 24.5 M | - | 19.1 M | 20.8 M | 21.3 M | - | 21.6 M | 22.3 M | 22.2 M | - | 22.1 M | 24 M | 22 M | - | 14 M | 13.8 M | 12.7 M | - | 10.7 M | 10.2 M | 6.07 M | - | 2.2 M | 2.3 M | 875 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency